TNDM Valuation

Tandem Diabetes Care Inc

Add to Watchlist

Advanced Chart

15.890

+0.45(2.915%)1D

Overview
Forecast
Valuation
Earnings

TNDM Relative Valuation

TNDM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TNDM is overvalued; if below, it's undervalued.

Historical Valuation

Tandem Diabetes Care Inc (TNDM) is now in the Undervalued zone, suggesting that its current forward PS ratio of 1.06 is considered Undervalued compared with the five-year average of -19.77. The fair price of Tandem Diabetes Care Inc (TNDM) is between 328.77 to 417.43 according to relative valuation methord. Compared to the current price of 15.50 USD , Tandem Diabetes Care Inc is Undervalued By 95.29%.

Relative Value

Fair Zone

328.77-417.43

Current Price：15.50

95.29%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

6.62

P/B

Median3y

7.49

Median5y

11.76

-0.35

FCF Yield

Median3y

-0.97

Median5y

-0.26

Competitors Valuation Multiple

The average P/S ratio for TNDM's competitors is 78.62, providing a benchmark for relative valuation. Tandem Diabetes Care Inc Corp (TNDM) exhibits a P/S ratio of 1.06, which is -98.66% above the industry average. Given its robust revenue growth of 22.30%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

TNDM.O

Tandem Diabetes Care Inc

1.06

Average P/S: 78.62

22.30%